FDA Approves Three Drugs for Nonprescription Use Through Rx-to-OTC Switch Process
February 14, 2020 -- The U.S. Food and Drug Administration today approved three drugs for nonprescription, or over-the-counter (OTC), use through a process called a prescription (Rx)-to-OTC switch. The FDA approved Voltaren Arthritis Pain... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 14, 2020 Category: General Medicine Source Type: news
Strides Pharma gets tentative nod from USFDA for pain relieving drug
Strides Pharma Global Pte Ltd, Singapore, has received tentative approval for Diclofenac Potassium Softgel Capsules, 25 mg from the United States Food& Drug Administration (USFDA), Strides Pharma Science said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 3, 2019 Category: Pharmaceuticals Source Type: news
Voltaren Ophthalmic (Diclofenac Sodium Ophthalmic Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 23, 2019 Category: Drugs & Pharmacology Source Type: news
GSK completes transaction with Pfizer to form new world-leading Consumer Healthcare Joint Venture
The Joint Venture brings together two highly complementary portfolios of trusted consumer health brands, including GSK's Sensodyne, Voltaren and Panadol and Pfizer's Advil, Centrum and Caltrate. Underpinned by science-based innovation, it is the global leader in OTC products and has number 1 or 2 market share positions in all key geographies, including the US and China. (Source: World Pharma News)
Source: World Pharma News - August 6, 2019 Category: Pharmaceuticals Tags: Featured GlaxoSmithKline Business and Industry Source Type: news
GSK, Pfizer complete deal to combine consumer health brands
GlaxoSmithKline and Pfizer said Thursday they have completed their previously announced deal to combine their consumer health care businesses.
The joint venture brings together GSK's consumer health brands, which include Sensodyne toothpaste and the pain relief products Voltaren and Panadol, with Pfizer’s anti-inflammatory medicine Advil, multivitamin Centrum and calcium supplement Caltrate. The combined product portfolio generates ann ual sales of more than $11 billion.
Under the terms of the… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 1, 2019 Category: Pharmaceuticals Authors: John George Source Type: news
diclofenac, Voltaren, Cataflam, Voltaren-XR, Cambia
Title: diclofenac, Voltaren, Cataflam, Voltaren-XR, CambiaCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 7/3/2019 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - July 3, 2019 Category: Rheumatology Source Type: news
Ketorolac vs. diclofenac
Title: Ketorolac vs. diclofenacCategory: MedicationsCreated: 6/20/2019 12:00:00 AMLast Editorial Review: 6/20/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - June 20, 2019 Category: Drugs & Pharmacology Source Type: news
Perrigo Announces FDA Final Approval For AB Rated Generic Version Of Voltaren(R) Gel 1%
DUBLIN, May 21, 2019 -- (Healthcare Sales & Marketing Network) -- Perrigo Company plc (NYSE; TASE: PRGO) today announced its partner received final approval from the U.S. Food and Drug Administration for its AB rated Abbreviated New Drug Application (ANDA... Biopharmaceuticals, Generics, FDA, Product Launch Perrigo, Voltaren, Voltaren Gel, diclofenac (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 21, 2019 Category: Pharmaceuticals Source Type: news
Pentazocine Cuts Acute Pancreatitis Pain Better Than Diclofenac Pentazocine Cuts Acute Pancreatitis Pain Better Than Diclofenac
In acute pancreatitis, the opioid pentazocine relieves pain better than the nonsteroidal anti-inflammatory drug (NSAID) diclofenac, a randomized controlled trial from India shows.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 17, 2019 Category: Consumer Health News Tags: Gastroenterology News Source Type: news
diclofenac and misoprostol (Arthrotec)
Title: diclofenac and misoprostol (Arthrotec)Category: MedicationsCreated: 11/22/1998 12:00:00 AMLast Editorial Review: 3/19/2019 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - March 19, 2019 Category: Rheumatology Source Type: news
Anti-inflammatory drug is the key to boosting cardiac reprogramming
(University of Tsukuba) University of Tsukuba researchers and colleagues developed a high-throughput screening system to identify the NSAID diclofenac as a factor responsible for enhancing cardiac reprogramming in postnatal and adult fibroblasts. Diclofenac functioned during early-stage reprogramming by silencing the cellular signature associated with fibroblasts and inhibiting COX-2 and other molecules associated with inflammation. Ant-inflammation could therefore be used to improve cardiac reprogramming associated with aging. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 6, 2019 Category: International Medicine & Public Health Source Type: news
Teva launches generic for Pfizer ’s Flector pain patch
Teva (NYSE:TEVA) said last week that it launched a generic version of Pfizer‘s (NYSE:PFE) Flector diclofenac epolamine patch.
Using a nonsteroidal anti-inflammatory drug, the topical patch is designed to treat acute pain due to minor strains, sprains and contusions.
Get the full story at our sister site, Drug Delivery Business News.
The post Teva launches generic for Pfizer’s Flector pain patch appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - March 4, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Drug-Device Combinations Pain Management Pharmaceuticals Wall Street Beat Pfizer Teva Pharmaceuticals Source Type: news
Licart (Diclofenac Epolamine Topical System) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 2, 2019 Category: Drugs & Pharmacology Source Type: news
Perrigo Launches Its AB Rated Generic Version of Solaraze(R) Gel 3%
DUBLIN, Nov. 27, 2018 -- (Healthcare Sales & Marketing Network) -- Perrigo Company plc (NYSE; TASE: PRGO) today announced it has launched its AB rated abbreviated new drug application referencing Solaraze® Gel, 3% (diclofenac sodium gel, 3%).
Solar... Biopharmaceuticals, Generics, Dermatology, Product Launch Perrigo, Solaraze, diclofenac (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 27, 2018 Category: Pharmaceuticals Source Type: news
Common painkiller tied to increased risk of heart problems
(Reuters Health) - The commonly used painkiller diclofenac may be linked with an increased risk of heart problems, a large Danish study suggests. (Source: Reuters: Health)
Source: Reuters: Health - September 21, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
